Tamim Niazi, MD, McGill University, Montreal, Quebec, Canada, explains the impact of the clinical implementation of dose escalation radiotherapy on patient quality of life in terms of treatment outcomes and convenience. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.